TIMP2 Polypeptide for Aging-Associated Cognitive Impairment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Aging leads to structural and neurophysiological changes in the nervous system, resulting in cognitive decline and susceptibility to degenerative disorders, with existing treatments failing to effectively address the underlying mechanisms of aging-associated cognitive impairment.
Innovation Solution
Enhancing Tissue Inhibitor of Metalloproteinase 2 (TIMP2) activity in mammals to treat aging-associated cognitive impairment by administering TIMP2 polypeptides or nucleic acids encoding TIMP2, which helps in maintaining cognitive integrity and counteracting age-related changes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for aging-associated cognitive impairment, then existing treatment protocols are applied, but they fail to effectively address the underlying mechanisms of aging-associated cognitive impairment
Solution Approach 1:
The patent uses TIMP2 as an intermediary substance to mediate between the administered compound and the target biological pathways. TIMP2 acts as a mediator that specifically inhibits MMP-9 and other matrix metalloproteinases, thereby protecting against cognitive impairment without directly interfering with the complex aging mechanisms. This intermediary approach allows the treatment to effectively address underlying mechanisms while maintaining reliability of the treatment protocol.
2Reliability
If TIMP2 activity is enhanced to treat aging-associated cognitive impairment, then cognitive functions are improved and synaptic plasticity is maintained, but the complexity of the treatment approach increases
Solution Approach 1:
The patent extracts and isolates the specific therapeutic action of TIMP2 enhancement from the complex process of treating aging-associated cognitive impairment. By focusing specifically on enhancing TIMP2 activity through administered compounds rather than attempting to address all aspects of cognitive decline simultaneously, the treatment simplifies the approach while maintaining reliability in protecting cognitive functions and synaptic plasticity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The enhancement of TIMP2 activity slows, stabilizes, or reverses cognitive decline, improving cognitive functions and maintaining synaptic plasticity, thereby addressing the root causes of aging-related cognitive impairments.
Implementation Method 1
Tissue inhibitor of metalloproteinase 2 (TIMP-2) is a member of a group of specific inhibitors of matrix metalloproteinases. The proteins these inhibitors regulate, matrix metalloproteinases (MMPs), play a role in several physiological processes including growth, wound healing, tissue repair, and cellular development and homeostasis.
Data Source
Figure 1A~2
AI summary
Methods of treating an adult mammal for an aging-associated condition are provided. Aspects of the methods include enhancing a TIMP activity, e.g., a TIMP2 activity, in the mammal in a manner sufficient to treat the adult mammal for the aging-associated condition. Also provided are compositions for use in practicing methods of the invention. A variety of aging-associated conditions may be treated by practice of the methods, which conditions include cognitive impairments.